Albireo Pharma Inc (NASDAQ:ALBO)

33.53
Delayed Data
As of Feb 23
 -0.28 / -0.83%
Today’s Change
15.31
Today|||52-Week Range
39.87
+30.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.001.0K1.0K0.00
 
 
 
Depreciation And Amortization1.0K5.0K8.0K10.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.0K-----10.0K
 
 
 
General Expenses3.1M6.0M6.7M6.9M
 
 
 
 
 
Other Operating Expenses0.0074.0K-65.0K-401.0K
 
 
 
 
Research And Development64.0K2.8M3.0M3.2M
 
 
 
 
 
Total Operating Expenses3.1M6.1M6.6M6.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.1M-6.1M-6.6M-6.5M
 
 
 
 
 
Extraordinary Credit0.000.00609.0K--
 
 
Extraordinary Charge-4.0K0.000.000.00
 
 
Interest Expense On Debt0.00249.0K152.0K--
 
 
 
Other Expenses0.00-325.0K-24.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.1M-6.7M-6.2M-6.5M
 
 
 
 
 
Income Taxes-3.0K0.000.000.00
 
 
Net Income-3.1M-6.7M-6.2M-6.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.1M6.3M7.2M8.9M
 
 
 
 
 
Shares To Calculate EPS Diluted2.1M6.3M7.2M8.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.50-$1.06-$0.86-$0.73
 
 
 
 
 
EPS Diluted-$1.50-$1.06-$0.86-$0.73